. . . . . . . . e82 2.4.3. Anticoagulation for AF in Patients With VHD e83 2.5. Evaluation of Surgical and Interventional Risk . . . e85 2.6. The Multidisciplinary Heart Valve Team and Heart Valve Centers . . . . . . . . . . . . . . . . . . . . . . . . . e86 2.7. Management of Patients With VHD After Valve Intervention . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . e88 2.7.1. Procedural Complications . . . . . . . . . . . . . . e89 2.7.2. Primary and Secondary Risk Factor Evaluation and Treatment . . . . . . . . . . . . . . e89 2.7.3. Persistent Symptoms After Valve Intervention . e89 2.7.4. Periodic Imaging After Valve Intervention . e89 3. Aortic Stenosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . e90 3.1. Stages of Valvular AS . . . . . . . . . . . . . . . . . . . . . . . . e90 3.2. Aortic Stenosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . e90 3.2.1. Diagnosis and Follow-Up . . . . . . . . . . . . . . . e90 3.2.2. Medical Therapy . . . . . . . . . . . . . 